Cumberland Pharmaceuticals
CPIX
30 hedge funds and large institutions have $32.9M invested in Cumberland Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
3% more funds holding
Funds holding: 29 → 30 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.51% less ownership
Funds ownership: 34.67% → 34.15% (-0.51%)
9% less capital invested
Capital invested by funds: $36.2M → $32.9M (-$3.36M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
+$1.82M |
| 2 |
Renaissance Technologies
New York
|
+$148K |
| 3 |
Prudential Financial
Newark,
New Jersey
|
+$56.9K |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$25.6K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$16.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JAM
JW Asset Management
Miami Beach,
Florida
|
-$1.2M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$749K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$490K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$65.1K |
| 5 |
Bank of New York Mellon
New York
|
-$28.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
SEI Investments
Oaks,
Pennsylvania
| $23K | +$3.08K | +492 | +15% |
|
|
OC
27
Oakworth Capital
Birmingham,
Alabama
| $19K | – | – | – |
|
28
UBS Group
Zurich,
Switzerland
| $17K | +$8.71K | +1,393 | +97% |
|
|
TRCT
29
Tower Research Capital (TRC)
New York
| $16K | +$14K | +2,238 | +519% |
|
|
JAM
30
JW Asset Management
Miami Beach,
Florida
| – | -$1.2M | -178,942 | Closed |
|
31
Bank of America
Charlotte,
North Carolina
| – | +$56 | +9 | New |
|
CPIX Hedge Fund Activity: Q2 2018 in Review
30 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q2 2018, worth a combined $32.9M — down 9.3% from $36.2M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CPIX positions and 1 closed out — a net gain of 1 holder — while 10 added to existing stakes and 7 trimmed.
The largest buyer was Ariel Investments, adding an estimated $1.82M. The largest seller was JW Asset Management, exiting entirely with an estimated $1.2M sold.
- 30 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q2 2018, up from 29 in Q1 2018.
- Funds reported $32.9M of Cumberland Pharmaceuticals stock for Q2 2018, down 9.3% quarter-over-quarter.
- 2 funds opened new Cumberland Pharmaceuticals positions in Q2 2018 and 1 closed out, a net change of +1 holder.
- The largest Cumberland Pharmaceuticals buyer in Q2 2018 was Ariel Investments, an estimated $1.82M added.
- The largest Cumberland Pharmaceuticals seller in Q2 2018 was JW Asset Management, an estimated $1.2M sold.
Based on aggregated 13F filings for Q2 2018.